ARCHIVES

DCT Advisors OK Recompetition Of Drug Contacts

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Fibrolast Interferon Contract Signed

May 2, 1980

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

August 30, 2013

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986